NM_000321.3:c.1389+5G>A
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PP3_StrongPP5_Moderate
The NM_000321.3(RB1):c.1389+5G>A variant causes a splice region, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000321.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RB1 | NM_000321.3 | c.1389+5G>A | splice_region_variant, intron_variant | Intron 14 of 26 | ENST00000267163.6 | NP_000312.2 | ||
RB1 | NM_001407165.1 | c.1389+5G>A | splice_region_variant, intron_variant | Intron 14 of 26 | NP_001394094.1 | |||
RB1 | NM_001407166.1 | c.1389+5G>A | splice_region_variant, intron_variant | Intron 14 of 16 | NP_001394095.1 | |||
LOC112268118 | XR_002957522.2 | n.40+180C>T | intron_variant | Intron 1 of 2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RB1 | ENST00000267163.6 | c.1389+5G>A | splice_region_variant, intron_variant | Intron 14 of 26 | 1 | NM_000321.3 | ENSP00000267163.4 | |||
RB1 | ENST00000650461.1 | c.1389+5G>A | splice_region_variant, intron_variant | Intron 14 of 26 | ENSP00000497193.1 |
Frequencies
GnomAD3 genomes Cov.: 30
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 30
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.1389+5G>A intronic pathogenic mutation (also known as g.76491G>A and IVS14+5G>A in some literature) results from a G to A substitution 5 nucleotides after coding exon 14 in the RB1 gene. This pathogenic mutation has been reported in several individuals affected with RB, and RT-PCR analyses have demonstrated that this mutation leads to exon 14 skipping (Alonso J et al. Hum. Mutat. 2001 May; 17(5):412-22; Houdayer C et al. Hum. Mutat. 2008 Jul; 29(7):975-82). In addition to the clinical data presented in the literature, alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at